Ovarian Cancer: Even Patients with New Infection benefit from Olaparib

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2019年 / 79卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [31] The promising PARP inhibitors in ovarian cancer therapy: From Olaparib to others
    Chen, Ying
    Du, Hui
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 : 552 - 560
  • [32] Olaparib in Platinum-Sensitive Ovarian Cancer
    Kaji, Daisuke
    Miura, Yuji
    Takano, Toshimi
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 179 - 179
  • [33] Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
    Zang, Rongyu
    Zhu, Jianqing
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)
  • [34] Prostate cancer with histone modifier UTX mutations can benefit from olaparib
    Muramoto, N.
    Iwasaki, M.
    Sera, Y.
    Ide, H.
    Horie, S.
    Honda, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S1578 - S1579
  • [35] An update on the safety of olaparib for treating ovarian cancer
    Cottrell, Kelsi
    Clark, Caroline L.
    Penson, Richard T.
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (04) : 447 - 451
  • [36] Profile of olaparib in the treatment of advanced ovarian cancer
    Chase, Dana M.
    Patel, Shreya
    Shields, Kristin
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2016, 8 : 125 - 129
  • [37] Safety evaluation of olaparib for treating ovarian cancer
    Lheureux, Stephanie
    Bowering, Valerie
    Karakasis, Katherine
    Oza, Amit M.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1305 - 1316
  • [38] Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations
    Moore, Kathleen N.
    Birrer, Michael J.
    ONCOLOGIST, 2018, 23 (06): : 697 - 703
  • [39] Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
    Ledermann, Jonathan A.
    Pujade-Lauraine, Eric
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [40] Exploring a New Quantitative Image Marker to Assess Benefit of Chemotherapy to Ovarian Cancer Patients
    Mirniaharikandehei, Seyedehnafiseh
    Patil, Omkar
    Aghaei, Faranak
    Wang, Yunzhi
    Zheng, Bin
    MEDICAL IMAGING 2017: IMAGING INFORMATICS FOR HEALTHCARE, RESEARCH, AND APPLICATIONS, 2017, 10138
12345